Search for: All records

Implantable neural interfaces are important tools to accelerate neuroscience research and translate clinical neurotechnologies. The promise of a bidirectional communication link between the nervous system of humans and computers is compelling, yet important materials challenges must be first addressed to improve the reliability of implantable neural interfaces. This perspective highlights recent progress and challenges related to arguably two of the most common failure modes for implantable neural interfaces: (1) compromised barrier layers and packaging leading to failure of electronic components; (2) encapsulation and rejection of the implant due to injurious tissue–biomaterials interactions, which erode the quality and bandwidth of signals across the biology–technology interface. Innovative materials and device design concepts could address these failure modes to improve device performance and broaden the translational prospects of neural interfaces. A brief overview of contemporary neural interfaces is presented and followed by recent progress in chemistry, materials, and fabrication techniques to improve in vivo reliability, including novel barrier materials and harmonizing the various incongruences of the tissue–device interface. Challenges and opportunities related to the clinical translation of neural interfaces are also discussed. 

Implantable electrophoretic drug delivery devices have shown promise for applications ranging from treating pathologies such as epilepsy and cancer to regulating plant physiology. Upon applying a voltage, the devices electrophoretically transport charged drug molecules across an ion‐conducting membrane out to the local implanted area. This solvent‐flow‐free “dry” delivery enables controlled drug release with minimal pressure increase at the outlet. However, a major challenge these devices face is limiting drug leakage in their idle state. Here, a method of reducing passive drug leakage through the choice of the drug co‐ion is presented. By switching acetylcholine's associated co‐ion from chloride to carboxylate co‐ions as well as sulfopropyl acrylate‐based polyanions, steady‐state drug leakage rate is reduced up to sevenfold with minimal effect on the active drug delivery rate. Numerical simulations further illustrate the potential of this method and offer guidance for new material systems to suppress passive drug leakage in electrophoretic drug delivery devices. 

The main goal of the field of neuromorphic computing is to build machines that emulate aspects of the brain in its ability to perform complex tasks in parallel and with great energy efficiency. Thanks to new computing architectures, these machines could revolutionize high-performance computing and find applications to perform local, low-energy computing for sensors and robots. The use of organic and soft materials in neuromorphic computing is appealing in many respects, for instance, because it allows better integration with living matter to seamlessly meld sensing with signal processing, and ultimately, stimulation in a closed-feedback loop. Indeed, not only can the mechanical properties of organic materials match those of tissue, but also, the working mechanisms of these devices involving ions, in addition to electrons, are compatible with human physiology. Another advantage of organic materials is the potential to introduce novel fabrication techniques relying on additive manufacturing amenable to one-of-a-kind form factors. This field is still nascent, therefore many concepts are still being proposed, without a clear winner. Furthermore, the field of application of organic neuromorphics, where bioinspiration and biointegration are extremely appealing, calls for a co-design approach from materials to systems.